The Cutting Edge of Medical Technology Content, Community & Collaboration
May 2009 - BioScience Venture Capital Investment Summary - from our friends @ OnBioVC
Colleagues,
As has become our custom ... please find last month's summary of venture capital investing in the U.S. "BioScience" sector from Adam Rubenstein @ OnBioVC.
Surprisingly, OnBioVC tracked 28 financings for May ‘09, versus 22 deals in May ‘08. May 2009 produced investments totaling $692.1M vs $355.3M in May 2008, yielding a month -over-month investment increase of 51%.
Skewing the May data was the largest reported deal...Boulder, CO-based Clovis Oncology, which closed a $145M Series A financing. This may seem outsized for a Series A investment, but I got a dose of reality from MedTech-IQ member Devinder Bawa, http://medtechiq.ning.com/profile/DevinderBawa, on what this may actually mean. Clovis intends to acquire, develop and commercialize innovative anti-cancer agents in the U.S., Europe and additional international markets.
Despite its drama in Sacramento with its state government financing, Callifornia continues its dominance in attracting investment dollars. California was home to 7 financings for May ‘09 that account for $153.4M. The Mid West was the next most active region, home to 6 financings spread across Minnesota (2), Michigan (2), Ohio (1) and Illinois (1) totaling $64.5M in investment.
Biopharma was the sector that attracted the lions share of investment dollars ($454.5M) for May ’09, followed by Devices ($234.1M).
Read Adam's excellent full report at: http://onbiovc.com/wp-content/uploads/2009/06/onbiovc-trend-analysi...
ENJOY!
CC
As has become our custom ... please find last month's summary of venture capital investing in the U.S. "BioScience" sector from Adam Rubenstein @ OnBioVC.
Surprisingly, OnBioVC tracked 28 financings for May ‘09, versus 22 deals in May ‘08. May 2009 produced investments totaling $692.1M vs $355.3M in May 2008, yielding a month -over-month investment increase of 51%.
Skewing the May data was the largest reported deal...Boulder, CO-based Clovis Oncology, which closed a $145M Series A financing. This may seem outsized for a Series A investment, but I got a dose of reality from MedTech-IQ member Devinder Bawa, http://medtechiq.ning.com/profile/DevinderBawa, on what this may actually mean. Clovis intends to acquire, develop and commercialize innovative anti-cancer agents in the U.S., Europe and additional international markets.
Despite its drama in Sacramento with its state government financing, Callifornia continues its dominance in attracting investment dollars. California was home to 7 financings for May ‘09 that account for $153.4M. The Mid West was the next most active region, home to 6 financings spread across Minnesota (2), Michigan (2), Ohio (1) and Illinois (1) totaling $64.5M in investment.
Biopharma was the sector that attracted the lions share of investment dollars ($454.5M) for May ’09, followed by Devices ($234.1M).
Read Adam's excellent full report at: http://onbiovc.com/wp-content/uploads/2009/06/onbiovc-trend-analysi...
ENJOY!
CC
Views: 1
MedTechIQ VideoLibrary
Upcoming Events
© 2024 Created by CC-Conrad Clyburn-MedForeSight.
Powered by
